The Promise and Perils of Diversity Action Plans for Clinical Trials
Varma T, Bierer B, Hantel A. The Promise and Perils of Diversity Action Plans for Clinical Trials. JAMA 2024, 332 PMID: 39302826, DOI: 10.1001/jama.2024.18225.Peer-Reviewed Original ResearchClinical trialsDiversity action plansUS Food and Drug Administration authorityTrialsFood and Drug Administration authority